Transcriptomics Based Network Analyses and Molecular Docking Highlighted Potentially Therapeutic Biomarkers for Colon Cancer
Related Experiment Video
Updated: Aug 14, 2025

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
Published on: July 22, 2020
Yun Wu1, Xiaoping Dong1, Jia Hu2
1National & Local Joint Engineering Laboratory of Animal Peptide Drug Development, College of Life Sciences, Hunan Normal University, Changsha, 410011, Hunan, China.
Abstract:
In this study, machine learning-based multiple bioinformatics analysis was carried out for the purpose of the deep and efficient mining of high-throughput transcriptomics data from the TCGA database. Compared with normal colon tissue, 2469 genes were significantly differentially expressed in colon cancer tissue. Gene functional annotation and pathway analysis suggested that most DEGs were functionally related to the cell cycle and metabolism. Weighted gene co-expression network analysis revealed a significant module and the enriched genes that were closely related to fatty acid degradation and metabolism. Based on colon cancer progression, the trend analysis highlighted that several gene sets were significantly correlated with disease development. At the same time, the most specific genes were functionally related to cancer cell features such as the high performance of DNA replication and cell division. Moreover, survival analysis and target drug prediction were performed to prioritize reliable biomarkers and potential drugs. In consideration of a combination of different evidence, four genes (ACOX1, CPT2, CDC25C and PKMYT1) were suggested as novel biomarkers in colon cancer. The potential biomarkers and target drugs identified in our study may provide new ideas for colonic-related prevention, diagnosis, and treatment; therefore, our results have high clinical value for colon cancer.
Insights
Machine learning identified key genes in colon cancer by analyzing transcriptomics data. Four novel biomarkers (ACOX1, CPT2, CDC25C, PKMYT1) show potential for diagnosis and treatment.
Area of Science:
- Bioinformatics
- Genomics
- Oncology
Background:
- High-throughput transcriptomics data offers insights into complex diseases.
- The TCGA database provides a valuable resource for cancer research.
Purpose of the Study:
- To mine TCGA transcriptomics data for colon cancer using machine learning.
- To identify novel biomarkers and potential therapeutic targets for colon cancer.
Main Methods:
- Machine learning-based bioinformatics analysis.
- Differential gene expression analysis.
- Gene co-expression network analysis.
- Survival analysis and drug prediction.
Main Results:
- Identified 2469 differentially expressed genes in colon cancer.
- Highlighted genes related to cell cycle, metabolism, and fatty acid degradation.
- Discovered significant correlations between gene sets and colon cancer progression.
- Proposed ACOX1, CPT2, CDC25C, and PKMYT1 as novel colon cancer biomarkers.
Conclusions:
- The identified biomarkers and drug targets offer potential for colon cancer prevention, diagnosis, and treatment.
- This study provides valuable insights for clinical applications in colon cancer management.

